Author

G. Miles

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Plant Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:plant (other)· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

A. B. Saltzman· 1 shared A. Gao· 1 shared A. Malovannaya· 1 shared B. Wen· 1 shared B. Zhang· 1 shared B.-J. Kim· 1 shared C. Huang· 1 shared C. Ma· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. B. Saltzman

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Two Liberibacter Effectors Combine to Suppress Critical Innate Immune Defenses and Facilitate Huanglongbing Pathogenesis in Citrus

S. Basu, L. Huynh, S. Zhang, R. Rabara, j. velasquez, H. Nguyen, G. Hao, G. Miles, Q. Shi, E. Stover, G. Gupta

The paper investigates two CLas effectors, P235 and Effector 3, showing they suppress citrus innate immune responses and contribute to HLB pathogenesis by inhibiting immune proteins and inducing cell death.

bioRxiv · Nov 26, 2021 · PreprintPlant Biology

Microscaled Proteogenomic Methods for Precision Oncology

S. Satpathy, E. J. Jaehnig, K. Krug, B.-J. Kim, A. B. Saltzman, D. Chan, K. R. Holloway, M. Anurag, C. Huang, P. Singh, A. Gao, N. Namai, Y. Dou, B. Wen, S. Vasaikar, , M. J. Ellis

This study develops microscaled proteogenomic methods for cancer analysis, showing treatment response and resistance mechanisms in ERBB2-positive breast cancers.

bioRxiv · Oct 9, 2019Cancer Biology